IRCT20200809048342N2招募中2 期
Clinical trial Phase II (proof of concept), three arms study on amelioration of peri-anal fistula in Crohn’s disease with Warton jelly Mesenchymal Stem Cells and its Secretome
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 75 years（—）
- 性别
- All
入选标准
- •Males or females between 18-75 years old with a clinically confirmed diagnosis of Crohn’s disease
- •Medical therapy resistant perianal fistula
- •Mild to moderate Crohn’s disease activity index
排除标准
- •Any reasons which reported as side effect of interventions
- •If participants would like to leave the trials for any reasons
- •Active infectious disease
- •Pregnant patient
- •Liver or kidney insufficiency
- •Underlying malignancy
- •Uncontrolled diabetes
- •History of chemoradiotherapy
- •Patients with immunodeficiency
- •Severe Crohn’s disease activity index
研究者
相似试验
进行中（未招募）
1 期
Study with stem cells from allogenic adipose tissue, in patients with HIV infetion.Infection for HIV with controlled viral load and immunological discordant responseMedDRA version: 18.1 Level: LLT Classification code 10001509 Term: AIDS System Organ Class: 100000004862EUCTR2014-000307-26-ESIniciativa Andaluza en Terapias Avanzadas-Fundación Pública Andaluza Progreso y Salud15
进行中（未招募）
不适用
Ensayo clínico de fase II, piloto, prospectivo, controlado, abierto, aleatorizado con grupos paralelos y multicéntrico para comparar la seguridad y la eficacia del ranibizumab en monoterapia frente a dos esquemas de combinación con terapia fotodinámica con verteporfina (TFDV) en pacientes con neovascularización coroidea (NVC) subfoveal secundaria a la degeneración macular asociada a la edad (DMAE).EUCTR2006-004131-30-ESDr. Félix Armadá
进行中（未招募）
2 期
An investigator-initiated, phase II clinical trial of the peptide-based cancer vaccine targeting WT1, DSP-7888, for colorectal adenomas in familial adenomatous polyposisFAPfamilial adenomatous polyposisJPRN-jRCT2051200082Shichijo Satoki30
招募中
2 期
Investigator-initiated clinical trial (Phase II) of cancer vaccine DSP-7888 for acute myeloid leukemia patients.Acute myeloid leukemiaD015470AMLJPRN-jRCT2051200023akata Jun100
进行中（未招募）
2 期
PARTNER: Platinum and PARP inhibitor for neoadjuvant treatment of triple-negative and/or BRCA-positive breast cancerMalignant neoplasm of breastBreast cancerCancerISRCTN58892741Cambridge University Hospitals NHS Foundation Trust780